Press Releases :: VolitionRx Ltd (VNRX)

Mar 26, 2025 8:00 am EDT

VolitionRx Announces Pricing of up to $2.3 Million Registered Direct Offering

Mar 25, 2025 9:30 am EDT

VolitionRx Limited Schedules Full Fiscal Year 2024 Earnings Conference Call and Business Update

Mar 21, 2025 8:30 am EDT

Volition's Nu.Q® Cancer Diagnostics Test Aims To Disrupt the Multi-Billion Dollar Liquid Biopsy Industry

Mar 20, 2025 8:30 am EDT

Volition Introduces Nu.Q® Cancer Blood Test in New Industry Primer for Lung Cancer

Mar 17, 2025 8:30 am EDT

Volition Proudly Sponsors the 44th ISICEM Congress

Mar 13, 2025 8:30 am EDT

Volition Signs first ever Nu.Q® Vet Cancer Test Automation Agreement with Fujifilm Vet Systems

Mar 11, 2025 8:30 am EDT

Volition Announces First Patient Enrolled in NTU Hospital's Prospective Validation Study of Nu.Q® Lung Cancer Test

Mar 4, 2025 8:30 am EST

Volition's Nu.Q® Discover Biomarkers to be utilized in Human Clinical Study Sponsored by Leading Pharmaceutical Company for the First Time

Feb 28, 2025 8:30 am EST

Volition Showcases Nu.Q® Vet Cancer Test at the 97th WVC Annual Conference

Feb 6, 2025 8:30 am EST

Volition Signs First Commercial Project Utilizing Rapid High-Throughput Model in the Study of NETosis

rss_feed News RSS